Michael R. Grunwald, MD, discusses new and emerging agents in acute myeloid leukemia and acute lymphoblastic leukemia, as well as sequencing and toxicity challenges with these treatments.
Original Article: Novel Agents Advance Acute Leukemia Treatment, But Challenges Remain